Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma 2024-06-19 19:30
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation 2024-06-19 19:00
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health 2024-06-19 18:10
Tang Prize in Biopharmaceutical Science Honoring Three Scientists 2024-06-19 12:15
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China 2024-06-19 09:00
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals 2024-06-17 22:00
Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress 2024-06-17 18:00
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024 2024-06-15 22:30
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 2024-06-15 20:50
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
2024ASCO｜Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations 2024-06-12 19:31
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) 2024-06-11 20:30
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility 2024-06-11 15:57
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024 2024-06-11 08:10
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024 2024-06-10 20:00
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study 2024-06-10 13:56
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024 2024-06-07 14:51
MicuRx: Successful Completion of Phase I Clinical Trial for Self-Developed MRX-8 Antibacterial Drug in China 2024-06-06 19:52
1 13 14 15 16 17 165